PhD: Development of a nanobody-based platform for Targeted Alpha Therapy (TAT)
AIBN Entrepreneurial PhD (2026)
Uma is a PhD student at the Australian Institute for Bioengineering and Nanotechnology (AIBN) at the University of Queensland. Her research is focused on the development of a nanobody-based platform for Targeted Alpha Therapy (TAT), a project conducted as an international collaboration between the AIBN and the Technical University of Denmark (DTU).
As a member of AMTAR, the ARC Hub for Advanced Manufacturing of Targeted Radiopharmaceuticals, she works at the intersection of Protein Engineering and Radiopharmaceutical Science. Her research aims to harness the high specificity of nanobodies to deliver potent alpha-emitting isotopes directly to cancer cells, helping to improve the precision of modern cancer treatment.
Uma holds an Integrated Master’s degree from India, completed in 2020. She later pursued a Master of Science by Research in Biology at the University of St Andrews, United Kingdom, graduating in 2023. This international academic background has provided her with a diverse technical toolkit and a global perspective on biotechnological innovation.
LinkedIn: Uma Maheshwari Bharathi
